Biomedical Engineering Reference
In-Depth Information
83 Boyce ST. 'Regulatory issues and standardization'. In
Methods of Tissue Engineering.
Atala A and Lanza R (eds). Academic Press, San Diego, 2001, 3-17.
84 US Department of Health and Human Services, Food and Drug Administration.
Use of
Materials Derived from Cattle in Medical Products Intended for use in Humans and
Drugs Intended for Use in Ruminants,
Proposed rule. Federal Register, 2007,
72
(8),
1581-617.
85 Wilkinson PJ and Clothier RH. 'Comparison of an animal product free medium and
normal growth supplement on the growth and barrier integrity of a human corneal
epithelial cell line.
ATLA-Alternatives to Laboratory Animals
, 2005,
33
(5), 509-18.
86 US Department of Health and Human Services, Food and Drug Administration.
Guid-
ance for Industry: Source Animal, Product, Preclinical, and Clinical Issues Concerning
the Use of Xenotransplantation Products in Humans
. Federal Register, 2003.
87 Li Y, Powell S, Brunette E, Lebkowski J and Mandalam R. 'Expansion of human
embryonic stem cells in defined serum-free medium devoid of animal-derived products'.
Biotechnology and Bioengineering
, 2005,
91
(6), 688-98.
88 Boyce ST, Hedge V, Hoath SB, Donnelly MM, Dodick JM, Childress CP and Supp AP.
'Initial characterization of stress analysis and keratinization of lifted vs submerged
dermal-epidermal cultured skin substitutes'.
Journal of Investigative Dermatology
,
1990,
94
(4), 509.
89 Ulubayram K, Aksu E, Gurhan SID, Serbetci K and Hasirci N. 'Cytotoxicity evaluation
of gelatin sponges prepared with different cross-linking agents'.
Journal of Biomaterials
Science Polymer Edition
, 2002,
13
(11), 1203-19.
90 Speer D, Chvapil M, Eskelson C and Ulreich J. 'Biological effects of residual glutaral-
dehyde in glutaraldehyde-tanned collagen biomaterials'.
Journal of Biomedical Materials
Research
, 1980,
14
(6), 753-64.
91 Cooke A, Oliver R and Edward M. 'An
in vitro
cytotoxicity study of aldehyde-treated pig
dermal collagen'.
British Journal of Experimental Pathology
, 1983,
64
(2), 172-6.
92 Powell HM and Boyce ST. 'Wound closure with EDC cross-linked cultured skin
substitutes grafted to athymic mice'.
Biomaterials
, 2007,
28
(6), 1084-92.
93 O'Brien FJ, Harley BA, Yannas IV and Gibson L. 'Influence of freezing rate on pore
structure in freeze-dried collagen-GAG scaffolds'.
Biomaterials
, 2004,
25
, 1077-86.
94 Ikuta S, Sekino N, Hara T, Saito Y and Chida K. 'Mouse epidermal keratinocytes in
three-dimensional organotypic coculture with dermal fibroblasts form a stratified
sheet resembling skin'.
Bioscience, Biotechnology and Biochemistry
, 2006,
70
(11),
2669-75.
95 Reneker D, Yarin A, Zussman E and Xu H. 'Electrospinning of nanofibers from polymer
solutions and melts'.
Advances in Applied Mechanics
, 2007,
41
, 43-95.
96 Chew S, Wen Y, Dzenis Y and Leong K. 'The role of electrospinning in the emerging
field of nanomedicine'.
Current Pharmaceutical Design
, 2006,
12
, 4751-70.
97 Matthews J, Wnek G, Simpson D and Bowlin G. 'Electrospinning of collagen nanofibers'.
Biomacromolecules
, 2002,
3
, 232-8.
98 Matthews JA, Boland ED, Wnek GE, Simpson DG and Bowlin GE. 'Electrospinning of
collagen type II: a feasibility study'.
Journal of Bioactive and Compatible Polymers
,
2003,
18
(2), 125-34.
99 Telemeco T, Ayres C, Bowlin GL, Wnek GE, Boland ED, Cohen N, Baumgarten CM,
Matthews J and Simpson DG. 'Regulation of cellular infiltration into tissue engineering
scaffolds comprised of submicron diameter fibrils produced by electrospinning'.
Biomaterials
, 2005,
1
, 377-85.
100
Powell HM and Boyce ST. 'Fiber density of electrospun gelatin scaffolds regulates
